AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR)Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Lymphoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized, parallel-group clinical trial in lymphoma patients with reduced cardiac function (left ventricular ejection fraction <50%) after anthracycline-based chemotherapy with two study groups: Group 1: Carvedilol and Lisinopril titrated to maximally tolerated doses as per standard practice Group 2: Pravastatin and Spironolactone in addition to maximally titrated Carvedilol and Lisinopril dosesMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04190433
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Joerg Herrmann, MD Mayo Clinic
Get Well Soon